Torrent Pharmaceuticals plans to raise Rs 12,500 crore through secured, rated NCDs via private placement. The fundraising follows committee approval and comes amid strong stock performance and robust earnings growth in the September quarter.
RR Kabel shares jump 10% as Q1 PAT surges 129% YoY, Ebitda doubles
RR Kabel reported a strong June-quarter performance, with profit after tax surging 129% year-on-year and Ebitda nearly doubling, driven by robust growth in its Wires